Luis Alberto Martinez-Juarez

Luis Alberto Martinez-Juarez

Auto-generated profile, based on publicly available information

Luis Alberto Martinez-Juarez

Carlos Slim Foundation, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2018 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
PNPatrick M Newman
Patrick M Newman
MFMolly F Franke
Molly F Franke
JAJafet Arrieta
Jafet Arrieta
HCHector Carrasco
Hector Carrasco
PEPatrick Elliott
Patrick Elliott
DPDaniel Palazuelos
Daniel Palazuelos
Background Non-communicable diseases (NCDs) contribute greatly to morbidity and mortality in low-income and middle-income countries (LMICs). Community health workers (CHWs) may improve disease control and medication adherence among patients with NCDs in LMICs, but data are lacking. We assessed the impact of a CHW-led intervention on disease control and adherence among patients with diabetes and/or hypertension in Chiapas, Mexico. Methods We conducted a prospective observational study among adult patients with diabetes and/or hypertension, in the context of a stepped-wedge roll-out of a CHW-led intervention. We measured self-reported adherence to medications, blood pressure and haemoglobin A1c at baseline and every 3 months, timed just prior to expansion of the intervention to a new community. We conducted individual-level mixed effects analyses of study data, adjusting for time and clustering by patient and community. Findings We analysed 108 patients. The CHW-led intervention was associated with a twofold increase in the odds of disease control (OR 2.04, 95% CI 1.15 to 3.62). It was also associated with optimal adherence assessed by 30-day recall (OR 1.86; 95% CI 1.15 to 3.02) and a positive self-assessment of adherence behaviour (OR 2.29; 95% CI 1.26 to 4.15), but not by 5-day recall. Interpretation A CHW-led adherence intervention was associated with disease control and adherence among adults with diabetes and/or hypertension. This study supports a role of CHWs in supplementing comprehensive primary care for patients with NCDs in LMICs. Trial registration number NCT02549495.

11 January 2022 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
PDF file
RWRosa María Wong-Chew
Rosa María Wong-Chew
ECEdwin Xchel Rodríguez Cabrera
Edwin Xchel Rodríguez Cabrera
CVCarlos Alberto Rodríguez Valdez
Carlos Alberto Rodríguez Valdez
JLJulieta Lomelin-Gascon
Julieta Lomelin-Gascon
LMLinda Morales-Juárez
Linda Morales-Juárez
RVRafael Ricardo Valdez-Vázquez
Rafael Ricardo Valdez-Vázquez
Several reports have emerged describing the long-term consequences of COVID-19 and its effects on multiple systems. As further research is needed, we conducted a longitudinal observational study to report the prevalence and associated risk factors of the long-term health consequences of COVID-19 by symptom clusters in patients discharged from the Temporary COVID-19 Hospital (TCH) in Mexico City. Self-reported clinical symptom data were collected via telephone calls over 90 days post-discharge. Among 4670 patients, we identified 45 symptoms across eight symptom clusters (neurological; mood disorders; systemic; respiratory; musculoskeletal; ear, nose, and throat; dermatological; and gastrointestinal). We observed that the neurological, dermatological, and mood disorder symptom clusters persisted in >30% of patients at 90 days post-discharge. Although most symptoms decreased in frequency between day 30 and 90, alopecia and the dermatological symptom cluster significantly increased (p < 0.00001). Women were more prone than men to develop long-term symptoms, and invasive mechanical ventilation also increased the frequency of symptoms at 30 days post-discharge. Overall, we observed that symptoms often persisted regardless of disease severity. We hope these findings will help promote public health strategies that ensure equity in the access to solutions focused on the long-term consequences of COVID-19.

1 January 2020 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
PDF file
DHDiego Abelardo Alvarez Hernández
Diego Abelardo Alvarez Hernández
LRLuisa Rivero-Zambrano
Luisa Rivero-Zambrano
LMLuis-Alberto Martínez-Juárez
Luis-Alberto Martínez-Juárez
RGRodolfo García-Rodríguez-Arana
Rodolfo García-Rodríguez-Arana

28 April 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HGHéctor Gallardo-Rincón
Héctor Gallardo-Rincón
MRMaría Jesús Ríos-Blancas
María Jesús Ríos-Blancas
JOJaninne Ortega-Montiel
Janinne Ortega-Montiel
AMAlejandra Montoya
Alejandra Montoya
LMLuis Alberto Martinez-Juarez
Luis Alberto Martinez-Juarez
RTRoberto Tapia-Conyer
Roberto Tapia-Conyer
Given the barriers to early detection of gestational diabetes mellitus (GDM), this study aimed to develop an artificial intelligence (AI)-based prediction model for GDM in pregnant Mexican women. Data were retrieved from 1709 pregnant women who participated in the multicenter prospective cohort study ‘Cuido mi embarazo’. A machine-learning-driven method was used to select the best predictive variables for GDM risk: age, family history of type 2 diabetes, previous diagnosis of hypertension, pregestational body mass index, gestational week, parity, birth weight of last child, and random capillary glucose. An artificial neural network approach was then used to build the model, which achieved a high level of accuracy (70.3%) and sensitivity (83.3%) for identifying women at high risk of developing GDM. This AI-based model will be applied throughout Mexico to improve the timing and quality of GDM interventions. Given the ease of obtaining the model variables, this model is expected to be clinically strategic, allowing prioritization of preventative treatment and promising a paradigm shift in prevention and primary healthcare during pregnancy. This AI model uses variables that are easily collected to identify pregnant women at risk of developing GDM with a high level of accuracy and precision.

8 June 2023 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
JBJaime Berumen
Jaime Berumen
LOLorena Orozco
Lorena Orozco
HRHéctor Gallardo Rincón
Héctor Gallardo Rincón
FRFernando Rivas
Fernando Rivas
EBElizabeth Barrera
Elizabeth Barrera
RTRoberto Tapia-Conyer
Roberto Tapia-Conyer
Background: This study investigated the effect of sex and age at type 2 diabetes (T2D) diagnosis on the influence of T2D-related genes, parental history of T2D, and obesity on T2D development.Methods: In this case–control study, 1012 T2D cases and 1008 healthy subjects were selected from the Diabetes in Mexico Study database. Participants were stratified by sex and age at T2D diagnosis (early, ≤ 45 years; late, ≥ 46 years). Sixty-nine T2D-associated single nucleotide polymorphisms were explored and the percentage contribution (R2) of T2D-related genes, parental history of T2D, and obesity (body mass index [BMI] and waist–hip ratio [WHR]) on T2D development was calculated using univariate and multivariate logistic regression models.Results: T2D-related genes influenced T2D development most in males who were diagnosed early (R2 = 23.5%; females,R2 = 13.5%; males and females diagnosed late,R2 = 11.9% andR2 = 7.3%, respectively). With an early diagnosis, insulin production-related genes were more influential in males (76.0% ofR2) while peripheral insulin resistance-associated genes were more influential in females (52.3% ofR2). With a late diagnosis, insulin production-related genes from chromosome region 11p15.5 notably influenced males while peripheral insulin resistance and genes associated with inflammation and other processes notably influenced females. Influence of parental history was higher among those diagnosed early (males, 19.9%; females, 17.5%) versus late (males, 6.4%; females, 5,3%). Unilateral maternal T2D history was more influential than paternal T2D history. BMI influenced T2D development for all, while WHR exclusively influenced males.Conclusions: The influence of T2D-related genes, maternal T2D history, and fat distribution on T2D development was greater in males than females.

1 June 2020 in eClinicalMedicine
Verified
Journal Article
Open access
LMLuis Alberto Martinez-Juarez
Luis Alberto Martinez-Juarez
ASAna Cristina Sedas
Ana Cristina Sedas
MOMiriam Orcutt
Miriam Orcutt
RBRaj Bhopal
Raj Bhopal